AXQ Capital LP Purchases New Holdings in Intuitive Surgical, Inc. $ISRG

AXQ Capital LP acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,356 shares of the medical equipment provider’s stock, valued at approximately $1,280,000.

A number of other institutional investors and hedge funds have also made changes to their positions in ISRG. Aaron Wealth Advisors LLC boosted its position in shares of Intuitive Surgical by 0.8% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after purchasing an additional 19 shares in the last quarter. Exencial Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 3.1% in the first quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock worth $327,000 after acquiring an additional 20 shares in the last quarter. Evergreen Capital Management LLC grew its stake in shares of Intuitive Surgical by 0.5% in the first quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock worth $2,124,000 after acquiring an additional 20 shares during the last quarter. Rise Advisors LLC increased its holdings in shares of Intuitive Surgical by 5.6% during the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock valued at $187,000 after acquiring an additional 20 shares in the last quarter. Finally, Texas Yale Capital Corp. raised its position in shares of Intuitive Surgical by 0.4% in the 1st quarter. Texas Yale Capital Corp. now owns 4,951 shares of the medical equipment provider’s stock worth $2,452,000 after purchasing an additional 21 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the transaction, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 116,164 shares of company stock valued at $61,916,172. 0.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ISRG has been the topic of several recent analyst reports. Sanford C. Bernstein reissued an “outperform” rating and set a $685.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, October 21st. Leerink Partners raised their price target on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Mizuho set a $575.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Evercore ISI increased their target price on Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. Finally, Robert W. Baird set a $655.00 target price on Intuitive Surgical in a report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $561.61 on Friday. The stock has a 50-day simple moving average of $492.09 and a two-hundred day simple moving average of $504.31. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The firm has a market capitalization of $201.32 billion, a PE ratio of 74.29, a P/E/G ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.84 earnings per share. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.